Bio-Rad Laboratories stockholders approved an amendment to the 2017 Incentive Award Plan, increasing the common stock reserve by 335,000 shares and extending the plan's expiration to 2036. Notably, shareholders rejected a proposal to alter the company's dual-class capital structure, thereby maintaining the current governance and voting power framework. These results, alongside the election of directors and ratification of auditors, signal investor support for the company's existing leadership and compensation structures.
